Volatus Aerospace Puts a Number on AISPECO: C$1.4 Million to C$2.6 Million in Annual Synergies

Volatus Aerospace has handed investors a concrete yardstick for judging its planned acquisition of Lithuanian sensor maker AISPECO UAB — and it sits some distance from the headline purchase price. Management told a webinar on Thursday that annual cost and direct synergies should land between C$1.4 million and C$2.6 million starting in the second year after closing. That figure, not the deal's sticker value, is what the integration will ultimately be measured against.

The company also flagged expected revenue synergies of C$7 million to C$12 million. Those two numbers describe very different things, and treating them as a single earnings boost would misread the transaction. Cost synergies flow straight to the expense line; additional revenue only reaches the bottom line after the costs of generating it are deducted.

A standalone business with its own trajectory

Stripped of any integration benefits, AISPECO generated roughly C$5.72 million in revenue during fiscal 2025, according to Volatus. The Canadian company projects that the unit, on a standalone basis, will reach about C$10 million in fiscal 2027. That forecast stands apart from the synergy estimates — investors weighing the deal need to track both the acquired business's own momentum and what Volatus can add on top of it.

AISPECO designs and builds airborne sensor systems and flight management software at its Lithuanian operations. The appeal is technological as much as commercial: the purchase brings specific engineering capabilities into the fold rather than simply adding top-line volume.

Three-quarters of the base price in stock

The agreement, struck Wednesday, covers all shares of AISPECO. The base consideration totals US$10.5 million, split between US$3.0 million in cash and US$7.5 million in Volatus shares. Sellers are therefore tied to the equity story rather than paid out largely in cash — a distinction that matters when reading the headline price.

On top of that sits an earn-out of up to US$2.5 million payable over three years, contingent on hitting milestones. It is neither a fixed payment nor an expense already incurred. Investors who focus only on the base figure overlook a possible second component; those who treat the earn-out as certain would be ignoring the conditions attached to it. Closing remains subject to customary terms, including conditional approval from the TSX.

A separate yardstick: hardware already delivered

While the AISPECO paperwork works its way toward completion, Volatus has a second data point that operates under a different set of rules. The company has shipped the first tranche of an ISR drone fleet to an unnamed NATO customer, a delivery worth roughly C$4.5 million. The underlying contract carries a potential total value of up to C$9 million.

That ceiling is a maximum, not a booked figure, and the distinction is the same one that runs through the whole AISPECO structure. What separates this order from a mere pipeline opportunity is that the customer has already begun exercising its option for additional units — a live commitment rather than a shot at a future tender.

Supplier status carries no guarantee

Volatus was named a qualified supplier for the Canadian government's Defence Drone Initiative Marketplace on September 3. The designation opens the door to bidding on future requirements; it promises neither a contract nor revenue.

Set side by side, the three disclosures sit at clearly different levels of obligation: an agreed acquisition still subject to conditions, a completed delivery with follow-on orders starting to flow, and a supplier listing with no order attached. For anyone assessing Volatus, those gradations say more than a blanket reading of every announcement as locked-in growth.

The share price, meanwhile, offered its own verdict. Volatus traded down 2.7% on the day, with media reports pointing to the AISPECO announcement as the company-specific trigger. The reaction reflects the structure investors are being asked to underwrite — a purchase funded largely in equity, with part of the consideration still contingent — rather than any verdict on the synergies themselves, which remain projections until the deal closes and the integration proves them out.